Evidence map›Paper›PMID 42026080›Full record

ArticleNature communications2026

TUSCO: benchmarking transcriptome reconstruction with endogenous single-isoform controls.

Tianyuan Liu, Alejandro Paniagua, Fabian Jetzinger, Luis Ferrández-Peral, Adam Frankish, Ana Conesa

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tianyuan LiuInstitute for Integrative Systems Biology (I2SysBio), Spanish National Research Council (CSIC), Paterna, 46980, Spain.ORCID http://orcid.org/0000-0002-8561-6239
Alejandro PaniaguaInstitute for Integrative Systems Biology (I2SysBio), Spanish National Research Council (CSIC), Paterna, 46980, Spain.ORCID http://orcid.org/0000-0002-0566-8830
Fabian JetzingerInstitute for Integrative Systems Biology (I2SysBio), Spanish National Research Council (CSIC), Paterna, 46980, Spain.ORCID http://orcid.org/0009-0000-3150-2167
Luis Ferrández-PeralInstitute for Integrative Systems Biology (I2SysBio), Spanish National Research Council (CSIC), Paterna, 46980, Spain.ORCID http://orcid.org/0000-0003-0338-0603
Adam FrankishEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SD, UK.ORCID http://orcid.org/0000-0002-4333-628X
Ana ConesaInstitute for Integrative Systems Biology (I2SysBio), Spanish National Research Council (CSIC), Paterna, 46980, Spain. ana.conesa@csic.es.ORCID http://orcid.org/0000-0001-9597-311X

Funding

GENCODE Resource ProjectU41HG007234 · NHGRI · SANGER INSTITUTE · PI FLICEK, PAUL · 2013 to 2020
$20.3M
EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 Marie Skłodowska-Curie Actions (H2020 Excellent Science - Marie Skłodowska-Curie Actions) 10107289Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.) 1R21HG011280-01NHGRI NIH HHS U41 HG007234
6 · The paper itself

Abstract

Long-read sequencing (LRS) platforms, such as Oxford Nanopore and Pacific Biosciences, enable comprehensive transcriptome analysis but face challenges such as sequencing errors, sample quality variability, and library preparation biases. Current benchmarking approaches address these issues insufficiently: BUSCO assesses transcriptome completeness using conserved single-copy orthologous genes but can misinterpret alternative splicing as gene duplications, while SIRV spike-ins and ERCCs oversimplify real sample complexity, neglecting RNA degradation and RNA-extraction artifacts, thus inflating performance metrics. Simulation algorithms are limited in their ability to recapitulate the complexity of real samples. To overcome these limitations, we introduce the Transcriptome Universal Single-isoform COntrol (TUSCO) benchmarking framework, centered on a curated TUSCO gene set of genes lacking alternative isoforms that can be confidently treated as an internal ground truth. The TUSCO evaluation quantifies precision by identifying reconstructed transcripts that deviate from reference annotations and quantifies sensitivity by verifying detection completeness in human and mouse samples. Masking TUSCO gene set transcripts and replacing them with modified splice variants in the annotation creates a TUSCO-novel challenge that assesses reconstruction of the true, now-unannotated isoforms. Our validation demonstrates that TUSCO metrics provide accurate and reliable benchmarking without external controls, significantly improving quality control standards for transcriptome reconstruction using LRS.

Indexed as

BenchmarkingGene Expression ProfilingTranscriptomeAlgorithmsAlternative SplicingAnimalsHigh-Throughput Nucleotide SequencingHumansMiceProtein IsoformsSequence Analysis, RNAProtein Isoforms

Identifiers

PMID42026080
PMCPMC13315946

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.